The identification of myocardial hibernation in patients with ischemic heart failure by echocardiography and radionuclide studies

Progress in Cardiovascular Diseases

Volumn 43, Issue 5, 2001, Pages 419-432

  Perrone Filardi, Pasquale ^a   Chiariello, Massimo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; RADIOISOTOPE; TECHNETIUM 99M;

CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; IMAGE QUALITY; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MEDICAL DECISION MAKING; MYOCARDIAL HIBERNATION; PATHOPHYSIOLOGY; PATIENT SELECTION; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 0035104039     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1053/pcad.2001.20649     Document Type: Article

References (89)

1. Surgical survival benefits for coronary disease patients with left ventricular dysfunction
2. Results of revascularization in patients with severe left ventricular dysfunction
3. The hibernating myocardium: Implications for management of congestive heart failure
4. Coronary artery bypass grafting in severe left ventricular dysfunction: Excellent survival with improved ejection fraction and functional state
5. Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy
6. The viable myocardium: Epidemiology, detection, and clinical implications
7. Reversible asynergy. Histopathologic and electrographic correlations in patients with coronary artery disease
8. Intervention ventriculography. Comparative value of nitroglycerin. Post-extrasystolic potentiation and nitroglycerin plus post-extrasystolic potentiation
9. Regional myocardial wall thickening response to nitroglycerin. A predictor of myocardial response to aortocoronary bypass surgery
10. Risk stratification and survival after myocardial infarction
11. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure
12. There may be more to myocardial viability than meets the eye!
13. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome
14. Serial changes in response of hibernating myocardium to inotropic stimulation after revascularization: A dobutamine echocardiographic study
15. Contractile reserve of dysfunctional myocardium after revascularization: A dobutamine stress echocardiography study
16. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: Comparison of pooled data
17. Identification of viable myocardium in patients with chronic coronary artery disease using rest-redistribution thallium-201 tomography: Optimal image analysis
18. Myocardial thallium-201 kinetics in normal and ischemic myocardium
19. Redistribution of thallium at rest in patients with stable and unstable angina and the effects of coronary artery bypass surgery
20. Transient defects on resting thallium scans in patients with coronary artery disease
21. 18F-fluorodeoxyglucose
22. 201Tl in patients with chronic coronary artery disease and left ventricular dysfunction
23. Current diagnostic techniques for assessing myocardial viability in hibernating and stunned myocardium
24. Thallium reinjection after stress-redistribution imaging: Enhanced detection of ischemic and viable myocardium
25. Comparison of thallium redistribution with rest "reinjection" imaging for the detection of viable myocardium
26. 18F-fluorodeoxyglucose positron emission tomography for assessing myocardial viability in patients with moderate versus severe left ventricular dysfunction
27. 201Tl activity in irreversible defects as a marker of myocardial viability. Clinicopathological study
28. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium following revascularization in patients with coronary artery disease
29. Stress-induced reversible and mild-to-moderate irreversible thallium defects. Are they equally effective in predicting recovery of regional left ventricular function after revascularization?
30. "Hibernating" myocardium: Asleep or part dead?
31. Non-uniformity of inner and outer systolic wall thickening in conscious dogs
32. Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary arterial bypass grafting
33. Rest-injected thallium-201 imaging for assessing viability of severe asynergic regions
34. Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability
35. Recovery of myocardial function
36. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary artery bypass surgery in patients with severely depressed left ventricular function
37. Dobutamine echocardiography and resting-redistribution thallium-210 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization
38. 99mTc-Sestamibi
39. 201thallium tomography vs dobutamine echocardiography
40. Quantitative thallium-201 and technetium-99m sestamibi tomography at rest in detection of myocardial viability in patients with chronic ischemic left ventricular dysfunction
41. Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting post-revascularization recovery
42. 201Tl uptake and comparative prediction of recovery of function
43. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography
44. Histological alterations in chronically hypoperfused myocardium. Correlations with PET findings
45. 99mTc sestamibi in patients undergoing cardiac transplantation. A scintigraphic/pathological study
46. 99mTc-sestamibi tomography before coronary bypass graft surgery. Correlation with histopathology and postoperative improvement in cardiac function
47. Rest technetium-99 sestamibi tomography in combination with short-term administration of nitrates: Feasibility and reliability for prediction of postrevascularization outcome of asynergic territories
48. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography
49. Residual coronary reserve identifies segmental viability in patients with wall motion abnormalities
50. Factors influencing regional myocardial contractile response to inotropic stimulation. Analysis in humans with stable ischemic heart disease
51. Relation between contractile reserve and positron emission tomographic patterns of perfusion and glucose utilization in chronic ischemic left ventricular dysfunction. Implications for identification of myocardial viability
52. Development of short-term myocardial hibernation. Its limitation by the severity of ischemia and inotropic stimulation
53. Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses
54. Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium
55. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty
56. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease. Implication of time course of recovery on diagnostic accuracy
57. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization
58. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease
59. 201Tl single-photon emission computed tomography
60. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium
61. Relation between blood flow and the severity of coronary artery stenosis
62. Hibernating myocardium. An incomplete adaptation to ischemia
63. Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization
64. Dobutamine echocardiography in predicting improvement in global left ventricular systolic function after coronary bypass or angioplasty in patients with healed myocardial infarcts
65. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography
66. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine echocardiography
67. Assessment of viable myocardium by dobutamine transesophageal echocardiography and comparison with fluorine-18 fluorodeoxyglucose positron emission tomography
68. Transesophageal dobutamine stress echocardiography for evaluation of patients with coronary artery disease
69. Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18-fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography
70. Identification of hibernating myocardium: Comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201tomography and dobutamine echocardiography
71. Relation between thallium uptake and contractile response to dobutamine. Implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction
72. Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPET. Correlation with histopathology in explanted hearts
73. Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease
74. Knowledge of perfusion and contractile reserve improves value of recovery of regional myocardial function postrevascularization. A study using the combination of myocardial contrast echocardiography and dobutamine echocardiography
75. Prognosis in patients with low left ventricular ejection fraction after myocardial infarction. Importance of exercise capacity
76. Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability
77. Low dose dobutamine echocardiography predicts improvement in functional capacity after exercise training in patients with ischemic cardiomyopathy: Prognostic implications
78. Assessing prognosis by means of radionuclide perfusion imaging: What technique and which variables should be used?
79. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction
80. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction
81. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular dysfunction
82. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction
83. Thallium reinjection versus standard stress/delay redistribution imaging for prediction of cardiac events
84. Prognostic value of persistent thallium-201 defects that become reversible after reinjection in patients with chronic myocardial infarction
85. Incremental prognostic value of thallium reinjection after stress-redistribution imaging in patients with previous myocardial infarction and left ventricular dysfunction
86. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction
87. 201Tl imaging for prognostic evaluation after myocardial infarction and thrombolysis
88. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy
89. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability